1. Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use
   Rachel Abbotts et al, 2022, Cancers CrossRef
2. Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
   Ping Chen et al, 2022, Clinical Pharmacokinetics CrossRef
3. Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer
   Francisco Quiñonero et al, 2023, International Journal of Nanomedicine CrossRef
4. Quantitative Analysis of the Efficacy of PARP Inhibitors as Maintenance Therapy in Recurrent Ovarian Cancer
   Lili Gao et al, 2021, Frontiers in Pharmacology CrossRef
5. Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer
   Garett J. Steers et al, 2022, Antioxidants CrossRef
6. High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients
   Manuela Giansanti et al, 2021, Cancers CrossRef